Edition:
India

aTyr Pharma reports qtrly ‍net loss per share, basic and diluted $0.43​


Wednesday, 15 Nov 2017 

Nov 14 (Reuters) - aTyr Pharma Inc ::aTyr Pharma announces third quarter 2017 operating results and provides corporate update.aTyr Pharma Inc - ‍expects that its cash, cash equivalents and investments will be sufficient to fund its anticipated operations into middle of 2019​.aTyr Pharma Inc qtrly ‍net loss per share, basic and diluted $0.43​.Q3 earnings per share view $-0.50 -- Thomson Reuters I/B/E/S. 

Company Quote

3.14
 --
11 Oct 2019